MARKET

LPCN

LPCN

Lipocine Inc
NASDAQ
6.52
+0.23
+3.66%
Opening 15:44 12/30 EST
OPEN
6.13
PREV CLOSE
6.29
HIGH
6.64
LOW
5.88
VOLUME
185.66K
TURNOVER
--
52 WEEK HIGH
6.72
52 WEEK LOW
2.520
MARKET CAP
36.20M
P/E (TTM)
-6.2940
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LPCN last week (1222-1226)?
Weekly Report · 1d ago
Lipocine Granted U.S. Patent For Hydroxyprogesterone Caproate Compositions And Methods Of Use In Preventing Preterm Birth
Benzinga · 12/23 19:34
Weekly Report: what happened at LPCN last week (1215-1219)?
Weekly Report · 12/22 09:59
Lipocine Advances Phase 3 Trial for PPD Treatment
TipRanks · 12/16 15:19
Lipocine Nears Full Enrollment In Phase 3 PPD Trial, Topline Results Expected Q2 2026
Benzinga · 12/16 13:10
Lipocine Nears Full Enrollment in Phase 3 Trial of Oral Brexanolone for Postpartum Depression
Reuters · 12/16 13:03
Lipocine Director Jeffrey Fink Resigns Effective January 1
Reuters · 12/15 21:06
Weekly Report: what happened at LPCN last week (1208-1212)?
Weekly Report · 12/15 10:04
More
About LPCN
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of therapeutics. The Company’s clinical development candidates include: LPCN 1154, oral brexanolone, for the treatment of postpartum depression, LPCN 2101, for the treatment of epilepsy, LPCN 2203, an oral candidate targeted for the management of essential tremor, LPCN 2401, an oral proprietary anabolic androgen receptor agonist for improved body composition in obesity management, and LPCN 1148, for the management of decompensated cirrhosis. It is also developing LPCN 1107, for the prevention of preterm birth, LPCN 1154, for rapid relief of postpartum depression, and LPCN 1144, for the treatment of metabolic dysfunction-associated steatohepatitis. Its product candidate, TLANDO, is a novel oral prodrug of testosterone containing testosterone undecanoate developed by the Company.

Webull offers Lipocine Inc stock information, including NASDAQ: LPCN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LPCN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LPCN stock methods without spending real money on the virtual paper trading platform.